Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Notes Payables: 2012-2018

Historic Notes Payables for Altimmune (ALT) over the last 5 years, with Dec 2018 value amounting to $71,596.

  • Altimmune's Notes Payables rose 286.02% to $632,000 in Q2 2020 from the same period last year, while for Jun 2020 it was $632,000, marking a year-over-year increase of 286.02%. This contributed to the annual value of $71,596 for FY2018, which is 44.05% up from last year.
  • Per Altimmune's latest filing, its Notes Payables stood at $71,596 for FY2018, which was up 44.05% from $49,702 recorded in FY2017.
  • In the past 5 years, Altimmune's Notes Payables ranged from a high of $458,629 in FY2016 and a low of $49,702 during FY2017.
  • Over the past 3 years, Altimmune's median Notes Payables value was $71,596 (recorded in 2018), while the average stood at $193,309.
  • Its Notes Payables has fluctuated over the past 5 years, first crashed by 89.16% in 2017, then soared by 44.05% in 2018.
  • Altimmune's Notes Payables (Yearly) stood at $458,629 in 2016, then slumped by 89.16% to $49,702 in 2017, then spiked by 44.05% to $71,596 in 2018.